CRISPR Therapeutics
CRSP
#3353
Rank
$4.41 B
Marketcap
$46.33
Share price
0.98%
Change (1 day)
9.73%
Change (1 year)

Financial Statements

Thumbnail CRISPR Therapeutics Financial Statement 2024

Financial Statement 2024

Language: English

View Financial Statement
Thumbnail CRISPR Therapeutics Financial Statement 2023

Financial Statement 2023

Language: English

View Financial Statement
Thumbnail CRISPR Therapeutics Financial Statement 2022

Financial Statement 2022

Language: English

View Financial Statement
Thumbnail CRISPR Therapeutics Financial Statement 2021

Financial Statement 2021

Language: English

View Financial Statement